Pinning Down Sihuan Pharmaceutical Holdings Group Ltd.'s (HKG:460) P/S Is Difficult Right Now
Feb 21
Have your own idea? Try our Stock Screener
Hong Kong (HSI) Pharma Industry Analysis
UpdatedFeb 21, 2025
DataAggregated Company Financials
Companies39
- 7D6.7%
- 3M2.1%
- 1Y1.5%
- YTD5.5%
Over the last 7 days, the Pharma industry has risen 6.7%, driven by gains from Hansoh Pharmaceutical Group of 13%. In the same time, Jilin Province Huinan Changlong Bio-pharmacy was down 13%. Overall in the last year, the industry is flat. As for the next few years, earnings are expected to grow by 12% per annum.
Industry Valuation and Performance
Has the Hong Kong Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 21 Feb 2025 | HK$442.5b | HK$463.0b | HK$31.9b | 8.6x | 13.9x | 1x |
| Sun, 19 Jan 2025 | HK$401.9b | HK$459.6b | HK$31.7b | 8.1x | 12.7x | 0.9x |
| Tue, 17 Dec 2024 | HK$431.1b | HK$461.4b | HK$31.8b | 8.4x | 13.5x | 0.9x |
| Thu, 14 Nov 2024 | HK$436.8b | HK$466.1b | HK$32.3b | 8.2x | 13.5x | 0.9x |
| Sat, 12 Oct 2024 | HK$513.6b | HK$474.1b | HK$32.9b | 7.9x | 15.6x | 1.1x |
| Mon, 09 Sep 2024 | HK$438.6b | HK$474.4b | HK$32.9b | 7.9x | 13.3x | 0.9x |
| Wed, 07 Aug 2024 | HK$433.7b | HK$464.8b | HK$33.0b | 7.4x | 13.2x | 0.9x |
| Fri, 05 Jul 2024 | HK$437.3b | HK$461.1b | HK$33.7b | 7.8x | 13x | 0.9x |
| Sun, 02 Jun 2024 | HK$456.4b | HK$464.5b | HK$34.0b | 8.2x | 13.4x | 1x |
| Tue, 30 Apr 2024 | HK$462.1b | HK$463.9b | HK$33.8b | 7.6x | 13.7x | 1x |
| Thu, 28 Mar 2024 | HK$458.9b | HK$468.2b | HK$33.6b | 7.8x | 13.7x | 1x |
| Sat, 24 Feb 2024 | HK$447.7b | HK$470.9b | HK$33.6b | 7.8x | 13.3x | 1x |
| Mon, 22 Jan 2024 | HK$420.2b | HK$472.3b | HK$33.8b | 6.9x | 12.4x | 0.9x |
| Wed, 20 Dec 2023 | HK$470.5b | HK$472.3b | HK$33.8b | 7.5x | 13.9x | 1x |
| Fri, 17 Nov 2023 | HK$506.0b | HK$469.8b | HK$32.0b | 6.9x | 15.8x | 1.1x |
| Sun, 15 Oct 2023 | HK$442.5b | HK$469.3b | HK$31.5b | 7.2x | 14x | 0.9x |
| Tue, 12 Sep 2023 | HK$430.9b | HK$469.7b | HK$31.6b | 6.8x | 13.6x | 0.9x |
| Thu, 10 Aug 2023 | HK$452.2b | HK$446.1b | HK$27.8b | 8.8x | 16.3x | 1x |
| Sat, 08 Jul 2023 | HK$476.9b | HK$445.9b | HK$27.8b | 9.4x | 17.2x | 1.1x |
| Mon, 05 Jun 2023 | HK$512.0b | HK$449.2b | HK$28.0b | 8.5x | 18.3x | 1.1x |
| Wed, 03 May 2023 | HK$570.3b | HK$453.4b | HK$28.5b | 9x | 20x | 1.3x |
| Fri, 31 Mar 2023 | HK$536.0b | HK$444.9b | HK$35.0b | 9.1x | 15.3x | 1.2x |
| Sun, 26 Feb 2023 | HK$601.4b | HK$443.4b | HK$35.0b | 11.7x | 17.2x | 1.4x |
| Tue, 24 Jan 2023 | HK$635.9b | HK$447.3b | HK$35.6b | 10.7x | 17.9x | 1.4x |
| Thu, 22 Dec 2022 | HK$590.7b | HK$441.7b | HK$34.7b | 10.3x | 17x | 1.3x |
| Sat, 19 Nov 2022 | HK$616.9b | HK$436.9b | HK$33.9b | 9.5x | 18.2x | 1.4x |
| Mon, 17 Oct 2022 | HK$535.5b | HK$513.5b | HK$38.9b | 8.2x | 13.8x | 1x |
| Wed, 14 Sep 2022 | HK$549.4b | HK$520.9b | HK$40.9b | 9.7x | 13.4x | 1.1x |
| Fri, 12 Aug 2022 | HK$594.4b | HK$514.4b | HK$51.6b | 8.1x | 11.5x | 1.2x |
| Sun, 10 Jul 2022 | HK$658.3b | HK$515.0b | HK$52.3b | 8.9x | 12.6x | 1.3x |
| Tue, 07 Jun 2022 | HK$567.0b | HK$515.9b | HK$52.1b | 9x | 10.9x | 1.1x |
| Thu, 05 May 2022 | HK$569.7b | HK$516.4b | HK$51.8b | 8.3x | 11x | 1.1x |
| Sat, 02 Apr 2022 | HK$635.8b | HK$526.1b | HK$53.1b | 8.6x | 12x | 1.2x |
| Mon, 28 Feb 2022 | HK$676.6b | HK$500.9b | HK$45.1b | 9.8x | 15x | 1.4x |
Price to Earnings Ratio
15x
Current Industry PE
- Investors are relatively neutral on the Hong Kong Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 14.5x.
- The 3-year average PS ratio of 1.1x is higher than the industry's current PS ratio of 0.96x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 11% per year over the last three years,
- Revenues have also declined 2.6% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the Hong Kong Healthcare industry?
| HK Market | 3.24% | |
| Healthcare | 10.49% | |
| Pharma | 6.66% | |
| Pharma | 6.66% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 3692 Hansoh Pharmaceutical Group | HK$19.80 | 13.0% +HK$13.5b | 48.9% | PE23.3x | |
| 1093 CSPC Pharmaceutical Group | HK$5.01 | 4.4% +HK$2.4b | -20.7% | PE10.4x | |
| 2096 Simcere Pharmaceutical Group | HK$7.90 | 12.9% +HK$2.2b | 42.3% | PS2.9x | |
| 1177 Sino Biopharmaceutical | HK$3.34 | 3.4% +HK$2.0b | 6.4% | PE26.5x | |
| 867 China Medical System Holdings | HK$8.30 | 7.5% +HK$1.4b | -35.2% | PE13.5x |
